Accession Number : ADA449474


Title :   Biotechnology


Corporate Author : INDUSTRIAL COLL OF THE ARMED FORCES WASHINGTON DC


Personal Author(s) : Annaballi, Angie ; Beaver, Jill ; Collie, John ; DeJesus, Rafael ; Gajdos, Jiri ; Jerome, Dave ; LeBlanc, Stewart ; Ngo, Linda ; Ray, Chris ; Royster, Ceceila ; Schalck, Mike


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/a449474.pdf


Report Date : Jan 2005


Pagination or Media Count : 60


Abstract : The United States biotechnology industry has grown tremendously since 1992, with revenues increasing from $8 billion in 1992 to $39.2 billion in 2003. As a result, biotechnology has revolutionized the way scientists view living matter their research and development efforts have led to the commercialization of many diverse products which have dramatically improved human and animal health, the world's food supply, and the quality of the environment. These successful applications of biotechnology are now viewed by private sector companies as well as governments throughout the world as being the catalysts of long-term economic growth, prosperity, and security. However, the United States, considered the current world leader in biotechnology, is being challenged by Asia for technological preeminence in this field. No longer content to dominate labor-intensive manufacturing, Asian governments are actively promoting biotechnology, nanotechnology, and information technology, and envision themselves becoming world leaders in these technologies three areas that are likely to generate the next wave of global technological innovation. This report summarizes the current state-of-the-art in biotechnology along with its economic and national security implications and examines biotechnology in the broader global context.


Descriptors :   *STATE OF THE ART , *GROWTH(GENERAL) , *BIOTECHNOLOGY , *ASIA , GLOBAL , UNITED STATES , NANOTECHNOLOGY , LONG RANGE(TIME) , INDUSTRIES , NATIONAL SECURITY , ECONOMICS


Subject Categories : Mfg & Industrial Eng & Control of Product Sys
      Bionics


Distribution Statement : APPROVED FOR PUBLIC RELEASE